Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
106M
-
Number of holders
-
125
-
Total 13F shares, excl. options
-
43.8M
-
Shares change
-
+2.28M
-
Total reported value, excl. options
-
$751M
-
Value change
-
+$13.2M
-
Put/Call ratio
-
0.16
-
Number of buys
-
71
-
Number of sells
-
-65
-
Price
-
$17.14
Significant Holders of Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) as of Q3 2020
160 filings reported holding RCUS - Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q3 2020.
Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) has 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.8M shares
of 106M outstanding shares and own 41.46% of the company stock.
Largest 10 shareholders include Alphabet Inc. (5.05M shares), BlackRock Inc. (3.13M shares), BVF INC/IL (2.6M shares), PFM Health Sciences, LP (2.54M shares), STATE STREET CORP (2.52M shares), FMR LLC (2.35M shares), VANGUARD GROUP INC (2.21M shares), BOXER CAPITAL, LLC (2.08M shares), Invus Financial Advisors, LLC (1.84M shares), and EcoR1 Capital, LLC (1.81M shares).
This table shows the top 125 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.